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An integrated evaluation of PAH exposure has to consider different routes of absorption, reliability and specificity of biomarkers of dose, and individual susceptibility.
The present study investigated the exposure to PAHs in coke oven workers (CO, n=100), asphalt pavers exposed to bitumen fumes (AW, n=98) and ground construction workers exposed to diesel exhausts (RC, n=47), by means of environmental and biological monitoring.
Personal exposure to total airborne PAHs [from naphtalene to indeno(1,2,3-cd)pyrene] in CO (median 140 μg/m3), was much higher than in AW (0.6 μg/m3), and in RC (0.4 μg/m3) workers. Urinary 1-hydroxypyrene (1-HOP) in end-shift samples was significantly higher in CO (2.2 μg/l) than in AW (0.7 μg/l) and in RC (0.4 μg/l) workers. An increasing trend in 1- HOP levels, over the workweek and the workshift was registered. A similar trend was observed for urinary 2-hydroxyfluorene (2-FLE) and 3-hydroxyphenanthrene (3-PHE) as well as for some unmetabolised PAH in urine. In smoking subjects with low exposures an important contribution to biomarkers was given by tobacco smoking. PAH-DNA adducts levels in peripheral blood lymphocytes were not associated with external exposure. Genetic polymorphisms of metabolic and DNA repairing enzymes (CYP1A1, GSTM1, GSTT1, XPD) did not appear to influence the levels of biomarkers. Total dermal contamination of PAHs, assessed in a subgroup of 22 AW, ranged from 23 to 623 μg. Significant correlations between dermal phenanthrene or pyrene and 1-HOP (r = 0.41 and 0.55), indicate that dermal exposure could contribute to the internal dose of these compounds.
Our results suggest that urinary biomarkers of PAHs, integrating exposure from all sources and routes, are reliable tools for risk assessment in occupational health.

